Delayed laparoscopic cholecystectomy for a patient with coronavirus disease 2019 who developed gangrenous

Yurie Yoshida1, Tomohiro Iguchi2, Norifumi Iseda1

  • 1Department of Surgery, Saiseikai Fukuoka General Hospital, 1-3-46 Tenjin, Chuo-ku, Fukuoka, 810-0001, Japan.

Surgical Case Reports
|July 17, 2022
PubMed

Insights

Gangrenous cholecystitis management was altered during the COVID-19 pandemic. A patient with asymptomatic COVID-19 successfully managed with antibiotics, delaying surgery until negative test results, avoiding complications.

Area of Science:

  • Hepatobiliary surgery
  • Infectious disease management
  • Pandemic response

Background:

  • Gangrenous cholecystitis necessitates early cholecystectomy due to high perforation and sepsis risks.
  • The COVID-19 pandemic significantly impacted emergent surgical management protocols to mitigate contagion and adverse outcomes.

Purpose of the Study:

  • To present a case of acute gangrenous cholecystitis in an asymptomatic COVID-19 patient.
  • To inform treatment strategies for similar cases during pandemics.

Main Methods:

  • A 56-year-old male presented with symptoms of acute gangrenous cholecystitis.
  • Initial management included antibiotics and planned percutaneous transhepatic gallbladder drainage (PTGBD) due to asymptomatic COVID-19 positivity.
  • Delayed laparoscopic cholecystectomy was performed after negative COVID-19 test results.

Main Results:

  • Antibiotic therapy alone proved effective, obviating the need for immediate PTGBD.
  • The patient's condition improved, allowing for a delayed laparoscopic cholecystectomy.
  • The delayed surgery resulted in an uneventful recovery.

Conclusions:

  • Acute gangrenous cholecystitis can occur in asymptomatic COVID-19 patients.
  • Conservative management with antibiotics and delayed surgery is a viable strategy during pandemics.
  • This case highlights the need for adaptive treatment protocols in emergent surgical conditions during global health crises.
Abstract